immune Fab (digoxin), and IV lipid emulsion (local anesthetic toxicity) Even when available, antidotes not diminish the need for meticulous monitoring and other supportive care Indiscriminant use of antidotes without other forms of management should be discouraged Table 102.10 summarizes a list of commonly used antidotes, suggested doses, and their indications for use Because of its frequent use, we next discuss naloxone